04-BS-13 · Undated paper
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
National Exam — May 2019, 04-BS-13, Biology. Three-hour, closed-book exam (one double-sided aid sheet permitted, approved Casio/Sharp calculator allowed). Format: Part I lists six 20-mark questions (Q1–Q6), and the instruction requires 3 of the 6, one from each pair (1&2), (3&4), (5&6); Part II lists three 20-mark questions (Q7–Q9), any 2 of 3. Together this matches the notice page's "FIVE questions constitute a complete exam" (3 + 2 = 5). All nine questions are solved below for completeness. Q4's stoichiometric equation (page 2) and its lettered sub-parts (page 3, "Given the following parameters for cell growth…") are one continuous question split across a page break not two separate questions; they are combined here. The source's page-3/4 footer reads "May 2018" against page-1/2's clear "May 2019" header. Q3, Q4, Q5, Q6, and Q9 are calculation/derivation questions; Q1, Q2, Q7, and Q8 are essay/qualitative questions.
Reference texts: Shuler & Kargi, Bioprocess Engineering: Basic Concepts (2nd ed., Prentice Hall) — elemental/electron balances, yield coefficients, maintenance (Pirt/Luedeking–Piret) corrections, respiratory quotient, fermenter energy balances; Madigan et al., Brock Biology of Microorganisms (15th ed., Pearson) — bacterial morphology, prokaryote/eukaryote comparison, viruses, fungi, diauxic growth and the lac operon; Toledo, Fundamentals of Food Process Engineering (3rd ed., Springer) — water activity and sorption.
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
(a) Data needed to design a bioreactor. Bioreactor design translates a target production rate into a vessel size, geometry, and set of operating conditions, so the designer needs data in five broad categories:
(b) Choice of reactor mode — two reasons each.
| Mode | Reason 1 | Reason 2 |
|---|---|---|
| Batch | Simple to operate, sterilize, and validate — no continuous sterile feed/effluent handling is needed, which lowers contamination risk and capital cost for small-volume or high-value products (e.g. many pharmaceuticals). | Well suited to unstable or genetically engineered strains, since the population is grown fresh each run and there is no long-term selection pressure for non-producing revertants, and it allows a single well-defined product specification per lot (important for regulatory batch release). |
| Fed-batch | Lets substrate be fed slowly to avoid substrate inhibition, catabolite repression, or overflow metabolism (e.g. avoiding the Crabtree effect/ethanol overflow in yeast at high glucose), so higher final cell/product densities are reached than in batch. | Allows the specific growth rate to be controlled directly via the feed rate (quasi-steady-state), which is valuable for producing secondary metabolites or recombinant proteins whose formation is optimal at a sub-maximal, controlled μ rather than at μmax. |
| Chemostat (continuous) | Operates at a true steady state (constant μ, x, s), which is ideal for physiological/kinetic studies because a single dilution rate D fixes μ = D and lets every other state variable be measured at a reproducible operating point. | Gives continuous, uninterrupted production without repeated turnaround (charge/sterilize/harvest) time, maximizing volumetric productivity for commodity products, provided the strain is stable enough not to be out-competed by non-producing mutants over long run times. |
This part is a design-knowledge/short-list question with no numerical data in the source; the categories and reasons above follow the standard bioprocess-engineering framework (Shuler & Kargi Ch. 1, 9) rather than any exam-specific figure.